Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Vanguard Capital Management LLC reported a 5.02% stake in Lixte Biotechnology Holdings, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.02% stake in Lixte Biotechnology Holdings, Inc., 622,756 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.02%
- Shares
- 622,756
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.02% | 622,756 |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Vanguard Capital Management LLC
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026
- Form 4 · Holloway Michael Andrew · Jul 2, 2026